4
Participants
Start Date
June 25, 2021
Primary Completion Date
March 21, 2022
Study Completion Date
March 21, 2022
Cerebrolysin
30 ml once daily (+70 ml 0.9% saline)
non-invasive brain stimulation
2 mA/35 cm² for 2x20 minutes, once daily
Placebo
100 ml once daily 0.9% saline
sham intervention
0 mA/35 cm² for 2x20 minutes, once daily Run-in phase consisting of ramp-up (10 seconds), stimulation (10 seconds), and ramp-down (10 seconds).
Klinik Pirawarth, Bad Pirawarth
Lead Sponsor
VASCage GmbH
OTHER
Ever Neuro Pharma GmbH
INDUSTRY